Evidence map›Paper›PMID 41860170›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Orthogonal Tri-Modular Coiled-Coil Assembly for Programmable Multi-Cargo Display on Escherichia coli Nissle 1917.

Yong Joon Cho, Gyu-Jin Lee, Jong-Ha Park, Sung In Lim

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yong Joon ChoDepartment of Chemical Engineering, Pukyong National University, Busan, Republic of Korea.
Gyu-Jin LeeDepartment of Chemical Engineering, Pukyong National University, Busan, Republic of Korea.
Jong-Ha ParkDepartment of Chemical Engineering, Pukyong National University, Busan, Republic of Korea.
Sung In LimDepartment of Chemical Engineering, Pukyong National University, Busan, Republic of Korea.ORCID https://orcid.org/0000-0003-0564-7893

Funding

National Research Foundation of Korea RS-2022-NR072043
6 · The paper itself

Abstract

Live biotherapeutic products (LBPs) represent emerging living medicines capable of site-specific intervention; however, current strategies for surface functionalization rely predominantly on static genetic fusion or covalent modification, limiting multiplexing and dynamic reconfiguration. Here, we engineer TriSCs (Tri-specific Scaffold Cells), a tri-modular and orthogonally programmable living scaffold based on Escherichia coli Nissle 1917. Three distinct α-helical motifs are displayed on the bacterial outer membrane, forming a reconfigurable biointerface that enables spontaneous, highly specific, and reversible payload assembly via coiled-coil interactions. This mix-and-go strategy allows simultaneous and selective recruitment of multiple functional modules without structural interference. Spatial co-display of a DR5 agonistic nanobody and an EGFR-targeting nanobody produces enhanced anticancer activity compared to soluble combinations, underscoring the impact of surface-organized signaling. In parallel, modular incorporation of a fluorescent reporter enables real-time bioimaging. By integrating orthogonality, reversibility, and multiplex capability within a single living chassis, TriSCs establish a dynamic and programmable LBP platform for precision theranostics and next-generation bioengineered therapeutics.

Indexed as

Escherichia coliBiological TherapyMicroorganisms, Genetically-Modifiedcoiled‐coil interactionslive biotherapeutic productsmultiplex surface displayorthogonal assemblyprogrammable living scaffold

Identifiers

PMID41860170
PMCPMC13181507

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.